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  Recent work shows that depression is intimately associated with changes in cognitive functioning, including memory, 
attention, verbal uency, and other aspects of higher-order cognitive processing. Changes in cognitive functioning are 
more likely to occur when depressive episodes are recurrent and to abate to some degree during periods of remission. 
However, with accumulating frequency and duration of depressive episodes, cognitive decits can become enduring, 
being evident even when mood improves. Such changes in cognitive functioning give depression links to mild cognitive 
impairment and thereby with neurodegenerative conditions, including Alzheimer’s disease, Parkinson’s disease, schizo-
phrenia, and multiple sclerosis. Depression may then be conceptualized on a dimension of depression – mild cognitive 
impairment – dementia. The biological underpinnings of depression have substantial overlaps with those of neurode-
generative conditions, including reduced neurogenesis, increased apoptosis, reactive oxygen species, tryptophan catab-
olites, autoimmunity, and immune-inammatory processes, as well as decreased antioxidant defenses. These evolving 
changes over the course of depressive episodes drive the association of depression with neurodegenerative conditions. 
As such, the changes in cognitive functioning in depression have important consequences for the treatment of depres-
sion and in reconceptualizing the role of depression in wider neuroprogressive conditions. Here we review the data on 
changes in cognitive functioning in recurrent major depression and their association with other central conditions.
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 Abbreviat ions: ACTH – adrenocort icotropic hormone; AD – Alzheimer’s disease; APOE – apolipoprotein E4; 
ASMT – N-Acetylserotonin O-methyltransferase; AVLT – auditory verbal learning test; AVP – arginine vaso-
pressin; BDNF – brain-derived neurotrophic factor; CES-D – Center for Epidemiologic Studies Depression scale; 
CFS – chronic fatigue syndrome; CHC – chronic hepatit is C; CNS – central nervous system; COPD – chronic ob-
structive pulmonary disease; CRF – corticotrophin releasing factor; HDRS – Hamilton Depression Rating Scale; 
HIOMT – hydroxyindole-O-methyltransferase; HPA – hypothalamic-pituitary-adrenal axis; IDO – indoleamine 
2,3-dioxygenase; IL – interleukin; LPS – bacterial lipopolysaccharide; MCI – mild cognitive impairment; 
MDA – malondialdehyde; MMSE – Mini-Mental State Examination; N-acetyl-5-methoxytryptamine – mel-
atonin; NAS – N-acetylserotonin; NCAM – neural cell adhesion molecule; NCWd – Naming Color of Words 
Dierent; NO – nitric oxide; OFC – orbitofrontal cortex; PD – Parkinson’s disease; PFC –prefrontal cortex; 
rDD – recurrent depressive disorders; REM – rapid eye movement; ROS – reactive oxygen species; SLE – sys-
temic lupus erythematosus; SSRIs – selective serotonin reuptake inhibitors; TAS – total antioxidant status; 
TDO – tryptophan 2,3-dioxygenase; TMT – Trail Making Test; TNF-a  – tumor necrosis factor-alpha; TPGs – thi-
ol protein groups; TrkB – tyrosine receptor kinase B; TRYCATs – tryptophan catabolites; VLPFC – ventrolater-
al prefrontal cortex
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